Best Of The IN VIVO Blog (06/2010)
Executive Summary
Best of the blog is a monthly column highlighting the best of our free online content at www.windhover.com/blog.
You may also be interested in...
Start-Up Spotlight: CorWave Takes Inspiration From Nature To Tackle Heart Failure
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.
Immunocore Aims For $100m IPO After Immunotherapy Success
The UK biotech is set for a NASDAQ launch which could propel to its first commercial launch by 2022
Another Failure For Biohaven’s Troriluzole
Biohaven’s investigational glutamate modulator troriluzole did not improve symptoms in patients with mild-to-moderate disease, adding to the list of failures in Alzheimer’s disease, as well as for the product itself.
Need a specific report? 1000+ reports available
Buy Reports